Masimo (MASI) Other Accumulated Expenses (2021 - 2022)
Masimo's quarterly Other Accumulated Expenses came in at $183.3 million in Q4 2022, up 160.37% year-on-year from $70.4 million in Q4 2021, and up 160.37% quarter-over-quarter from $70.4 million in Q1 2022.
Masimo has reported Other Accumulated Expenses for 2 years, with the latest figure at $183.3 million in Q4 2022.
- For the quarter ending Q4 2022, Other Accumulated Expenses rose 160.37% year-over-year to $183.3 million; the trailing twelve-month figure through Dec 2022 stood at $183.3 million (up 160.37% YoY), and the FY2022 full-year result was $183.3 million, up 160.37% from the prior year.
- Other Accumulated Expenses for Q4 2022 stood at $183.3 million, up from $70.4 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $183.3 million in Q4 2022, with the low at $53.2 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 183.30 Mn |
| Jan 1, 2022 | 70.40 Mn |
| Jan 2, 2021 | 53.24 Mn |